Portland Hill Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$153K Hold
1,151
0.37% 22
2023
Q4
$144K Hold
1,151
0.38% 20
2023
Q3
$140K Hold
1,151
0.36% 22
2023
Q2
$162K Hold
1,151
0.38% 22
2023
Q1
$164K Hold
1,151
0.38% 23
2022
Q4
$180K Hold
1,151
0.5% 25
2022
Q3
$164K Hold
1,151
0.31% 28
2022
Q2
$153K Hold
1,151
0.21% 31
2022
Q1
$158K Hold
1,151
0.14% 31
2021
Q4
$199K Hold
1,151
0.15% 26
2021
Q3
$167K Hold
1,151
0.11% 29
2021
Q2
$151K Hold
1,151
0.09% 28
2021
Q1
$148K Hold
1,151
0.1% 27
2020
Q4
$136K Hold
1,151
0.1% 23
2020
Q3
$132K Hold
1,151
0.11% 23
2020
Q2
$130K Hold
1,151
0.13% 22
2020
Q1
$93K Hold
1,151
0.12% 21
2019
Q4
$122K Buy
+1,151
New +$120K 0.12% 21

Other funds holding DGX

Portland Hill Asset Management's DGX Position: Q1 2024 in Review

Portland Hill Asset Management held its Quest Diagnostics (DGX) position steady in Q1 2024 at 1,151 shares worth $153K. The position accounts for 0.37% of the portfolio, ranked #22.

Portland Hill Asset Management first reported a position in DGX in Q4 2019 and has held it in 18 quarters since. The position peaked at $199K in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Portland Hill Asset Management held 1,151 shares of Quest Diagnostics worth $153K as of Q1 2024.
  • Portland Hill Asset Management left its Quest Diagnostics share count unchanged in Q1 2024.
  • Quest Diagnostics made up 0.37% of Portland Hill Asset Management's portfolio in Q1 2024, its #22 holding.
  • Portland Hill Asset Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 18 quarters since.
  • Portland Hill Asset Management's Quest Diagnostics position peaked at $199K in Q4 2021.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Portland Hill Asset Management's 13F filing for Q1 2024, filed 15 May 2024.